ALEXANDRA JANSEN: Open Payments
NPI 1720469976 · CUMMING, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 77 payments from 9 companies in 2025. Trend: 2023 $1,597 · 2024 $528 · 2025 $1,714
Food & beverage: $1,405Education: $308
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 36 | $531 |
| Genentech USA, Inc. | 22 | $373 |
| AstraZeneca Pharmaceuticals LP | 7 | $361 |
| SANOFI-AVENTIS U.S. LLC | 3 | $300 |
| Novartis Pharmaceuticals Corporation | 4 | $76 |
| Galderma Laboratories, L.P. | 2 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Organon LLC | 1 | $8 |
Products named: DUPIXENT, Xolair, TEZSPIRE, AIRSUPRA, Rhapsido, NEMLUVIO, NEFFY, NUCALA.
Industry payments across IA — which companies pay providers there.
